Zhittya Logo.jpg
Zhittya Genesis Medicine Announces: Landmark fMRI Study Reveals 21.2% Boost in Brain Blood Flow in Parkinson’s Patient Following Six Months of Intranasal FGF-1 Therapy
February 27, 2025 11:00 ET | Zhittya Genesis Medicine Inc
Groundbreaking fMRI study that showed a 21.2% increase in brain blood flow in a Parkinson’s patient after six months of intranasal FGF1 therapy.
Zhittya Logo.jpg
Autism: Is This a Vascular Disease and Would Therapeutic Angiogenesis Be a Potential Treatment?
August 15, 2023 08:00 ET | Zhittya Genesis Medicine Inc
LAS VEGAS, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Dr. Jack Jacobs, Chief Science Officer of Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), will be presenting at the online AutismOne...
Featured Image for Brooks Rehabilitation
MagTrack Technology Opens Doors for Independent Operation of Smartphones, Computers, Other Devices for Wheelchair Users
February 09, 2022 06:45 ET | Brooks Rehabilitation
JACKSONVILLE, Fla., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Brooks Rehabilitation is pleased to announce the MagTrack study, a collaborative research endeavor between Brooks and the Georgia Tech School of...
ENT and Allergy logo
ENT and Allergy Associates(R) Announce ImThera Medical Clinical Study
May 28, 2015 14:48 ET | Ent and Allergy
TARRYTOWN, N.Y., May 28, 2015 (GLOBE NEWSWIRE) -- The following is a message from Dr. Ofer Jacobowitz, partner of ENT and Allergy Associates: Sleep apnea is a serious and dangerous disease where...